SCHEMBL20495149

SCHEMBL20495149

N#Cc1cccc(-c2ccc3[nH]c(C(Cl)(Cl)Cl)nc3c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.42
USP30 Q70CQ3 2/20 0.42
MAP4K4 O95819 1/20 0.41
PTPN5 P54829 1/20 0.41
XDH P47989 1/20 0.41
CLK4 Q9HAZ1 2/20 0.41
RHEB Q15382 1/20 0.40
MCHR1 Q99705 1/20 0.40
IDO1 P14902 2/20 0.40
ALDH1A3 P47895 1/20 0.40
CYP19A1 P11511 1/20 0.40
MAOB P27338 1/20 0.40
PGR P06401 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
GSK3B P49841 1/20 0.39
CSNK1G2 P78368 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15311107 0.86 KCNH2 (0.43) ABL1USP30MAP4K4PTPN5XDH
SCHEMBL15625905 0.86 MAPK10 (0.44) RHEBCYP19A1CSNK1A1CSNK1DGSK3B
SCHEMBL5512134 0.83 DYRK3 (0.42) CLK4ALDH1A1CYP3A4GSK3B
SCHEMBL20982453 0.82 RHEB (0.52) ABL1USP30MAP4K4XDHCLK4
SCHEMBL30798899 0.81 ABL1 (0.46) ABL1USP30MAP4K4XDHCLK4
SCHEMBL21822330 0.77 PIN1 (0.54) CSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL20495425 0.76 PIN1 (0.61) ABL1XDHMCHR1
SCHEMBL20494892 0.73 DGAT1 (0.42) ALDH1A1CYP1A2GSK3B
SCHEMBL15245240 0.73 DGAT1 (0.65) PTPN5RHEBMCHR1
SCHEMBL20495460 0.72 NPC1 (0.44) ABL1ALDH1A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11180459-B2 Bacterial efflux pump inhibitors RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2021-11-23 US disclosed
US-11180459-B2 Bacterial efflux pump inhibitors RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2021-11-23 US disclosed
US-20200140393-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERISTY OF NEW JERSEY (US) 2020-05-07 US disclosed
US-20200140393-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERISTY OF NEW JERSEY (US) 2020-05-07 US disclosed
WO-2018165612-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2018-09-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11180459-B2 Bacterial efflux pump inhibitors ABCB11, ABCB1, SLC47A1 ABL1 1676/4885USP30 3597/4885MAP4K4 2890/4885
US-20200140393-A1 BACTERIAL EFFLUX PUMP INHIBITORS ABCB11, ABCB1, SLC47A1 ABL1 1676/4885USP30 3597/4885MAP4K4 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.